SCHEMBL4958287

SCHEMBL4958287

O=Cc1ccc(F)c(-c2ccccc2Cl)c1OCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.40
LMNA P02545 1/20 0.39
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
PTGER1 P34995 2/20 0.37
ERN1 O75460 2/20 0.37
HTR1A P08908 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CDK4 P11802 1/20 0.35
CCNB1 P14635 1/20 0.35
CCND1 P24385 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
FABP4 P15090 1/20 0.35
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4960882 0.89 LMNA (0.42) KDM1ALMNAALOX5APFEN1PTGER1
SCHEMBL4962154 0.88 LMNA (0.39) LMNAALOX5APFEN1PTGER1ERN1
SCHEMBL4957324 0.85 KDM1A (0.40) KDM1ALMNAPTGER1ERN1HTR1A
SCHEMBL4961226 0.81 KDM1A (0.42) KDM1ALMNAALOX5APFEN1PTGER1
SCHEMBL4960000 0.79 HTR1A (0.42) LMNAPTGER1ERN1HTR1AADRA1D
SCHEMBL21647646 0.78 KDM1A (0.43) KDM1AERN1HTR1ACCNB2CDK1
SCHEMBL4958314 0.78 LMNA (0.39) LMNAALOX5APFEN1PTGER1ERN1
SCHEMBL4958641 0.77 RXRA (0.38) LMNAALOX5APFEN1PTGER1ERN1
SCHEMBL7398752 0.77 HTR1A (0.50) LMNAHTR1AADRA1DADRA1AADRA1B
SCHEMBL16033831 0.76 KDM1A (0.47) KDM1AERN1HTR1ACCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871759-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2008-01-02 EP disclosed
WO-2006116158-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF WYETH (US) 2006-11-02 WO disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof HTR2C, HTR1D, HTR1A KDM1A 1156/4885LMNA 2921/4885ALOX5AP 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.